#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Jeanette Bjorkquist Email
Executive Director, Accounting & Treasury . Assembly Biosciences
San Francisco, CA
LocationPrimary Email
How to contact Jeanette Bjorkquist
Join and see Jeanette's contact info for free!Phone
Current Roles
Employees:
84Revenue:
$7.3MAbout
Assembly Biosciences, Inc. (Nasdaq: ASMB) is a public clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome. Assembly is developing two innovative platform programs: an HBV program advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a microbiome program developing novel oral live biotherapeutics designed to address diseases associated with the microbiome. Assembly's HBV program is advancing multiple drug candidates with the aim of increasing cure rates in patients with chronic HBV. The company's microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current Good Manufacturing Practices and a patent-pending delivery system, GEMICEL®, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. Assembly is developing a robust pipeline of product candidates in multiple disease indications. For more information, visit www.assemblybio.com. Company headquarters in Carmel, IN and San Francisco, CA.Assembly Biosciences Address
331 Oyster Point BlvdSan Francisco, CA
United States